Nouscom is a private clinical stage immuno-oncology company developing next-generation, off-the-shelf and personalized cancer vaccines. Our proprietary viral vector platform has the capacity to encode for large payloads of neoantigens or other immunomodulators and is clinically
Territory will include multiple countries in the EU.Serving as a value-added resource and extension of the Company the Clinical Trial Liaison (CTL) will support the companys Ophthalmology & Neurology pipeline. The CTL supports the execution of country medical
Territory will include multiple countries in the EU. Serving as a value-added resource and extension of the Company the Clinical Trial Liaison (CTL) will support the companys Ophthalmology & Neurology pipeline. The CTL supports the execution of country